Zymeworks Presents New Phase 1 Data for ZW191, a Folate Receptor Alpha-Targeting ADC at AACR Annual Meeting 2026
Go back to Zymeworks Presents New Phase 1 Data for ZW191, a Folate Receptor Alpha-Targeting ADC at AACR Annual Meeting 2026| (NASDAQ: ZYME) | Delayed: 23.21 +0.07 (0.30%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $23.14 | 52 Week High | $ | |||
| Open | $23.51 | 52 Week Low | $ | |||
| Day High | $23.62 | P/E | N/A | |||
| Day Low | $23.05 | EPS | $ | |||
| Volume | 309,051 | |||||

